ID   CTL2_HUMAN              Reviewed;         706 AA.
AC   Q8IWA5; B2RBB1; B3KNH3; B4DFJ0; F2Q9D7; Q658V1; Q658Z2; Q6PJV7; Q8N2F0;
AC   Q9NY68;
DT   30-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 3.
DT   28-JUN-2023, entry version 162.
DE   RecName: Full=Choline transporter-like protein 2 {ECO:0000305};
DE   AltName: Full=Solute carrier family 44 member 2;
GN   Name=SLC44A2 {ECO:0000312|HGNC:HGNC:17292}; Synonyms=CTL2;
GN   ORFNames=PSEC0210;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING (ISOFORM 1),
RP   FUNCTION, VARIANT ARG-154, AND TRANSPORTER ACTIVITY.
RX   PubMed=10677542; DOI=10.1073/pnas.030339697;
RA   O'Regan S., Traiffort E., Ruat M., Cha N., Compaore D., Meunier F.-M.;
RT   "An electric lobe suppressor for a yeast choline transport mutation belongs
RT   to a new family of transporter-like proteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:1835-1840(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), DISEASE, TISSUE SPECIFICITY, AND
RP   VARIANT ARG-154.
RC   TISSUE=Epithelium, and Inner ear;
RX   PubMed=14973250; DOI=10.1523/jneurosci.5063-03.2004;
RA   Nair T.S., Kozma K.E., Hoefling N.L., Kommareddi P.K., Ueda Y., Gong T.-W.,
RA   Lomax M.I., Lansford C.D., Telian S.A., Satar B., Arts H.A.,
RA   El-Kashlan H.K., Berryhill W.E., Raphael Y., Carey T.E.;
RT   "Identification and characterization of choline transporter-like protein 2,
RT   an inner ear glycoprotein of 68 and 72 kDa that is the target of antibody-
RT   induced hearing loss.";
RL   J. Neurosci. 24:1772-1779(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Santoso S.S., Bayat B.B., Sachs U.;
RT   "Detection of HNA-3b antibodies in patient sera.";
RL   Submitted (APR-2011) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 565-706 (ISOFORM 2), AND VARIANT ARG-154.
RC   TISSUE=Brain cortex, Placenta, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ARG-154.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT ARG-154.
RC   TISSUE=Eye, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 60-706 (ISOFORM 1), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 273-706 (ISOFORM 2), AND VARIANT ARG-154.
RC   TISSUE=Stomach;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 321-706 (ISOFORM 1).
RC   TISSUE=Embryo;
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-length
RT   human cDNAs encoding secretion or membrane proteins from oligo-capped cDNA
RT   libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 663-706 (ISOFORM 3).
RA   Yu W., Gibbs R.A.;
RL   Submitted (JUN-1998) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   INTERACTION WITH COCH.
RX   PubMed=17926100; DOI=10.1007/s10162-007-0099-2;
RA   Kommareddi P.K., Nair T.S., Raphael Y., Telian S.A., Kim A.H., Arts H.A.,
RA   El-Kashlan H.K., Carey T.E.;
RT   "Cochlin isoforms and their interaction with CTL2 (SLC44A2) in the inner
RT   ear.";
RL   J. Assoc. Res. Otolaryngol. 8:435-446(2007).
RN   [12]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-187 AND ASN-200.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of multiple
RT   enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [13]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-187 AND ASN-200.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-linked
RT   cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [14]
RP   FUNCTION, ALTERNATIVE PROMOTER USAGE, TISSUE SPECIFICITY, AND TRANSPORTER
RP   ACTIVITY.
RX   PubMed=20665236; DOI=10.1007/s10930-010-9268-y;
RA   Kommareddi P.K., Nair T.S., Thang L.V., Galano M.M., Babu E., Ganapathy V.,
RA   Kanazawa T., McHugh J.B., Carey T.E.;
RT   "Isoforms, expression, glycosylation, and tissue distribution of
RT   CTL2/SLC44A2.";
RL   Protein J. 29:417-426(2010).
RN   [15]
RP   FUNCTION, AND TRANSPORTER ACTIVITY.
RX   PubMed=23651124; DOI=10.1111/jnc.12298;
RA   Song P., Rekow S.S., Singleton C.A., Sekhon H.S., Dissen G.A., Zhou M.,
RA   Campling B., Lindstrom J., Spindel E.R.;
RT   "Choline transporter-like protein 4 (CTL4) links to non-neuronal
RT   acetylcholine synthesis.";
RL   J. Neurochem. 126:451-461(2013).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-14, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [18]
RP   FUNCTION, TRANSPORTER ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=33789160; DOI=10.1016/j.jbc.2021.100604;
RA   Taylor A., Grapentine S., Ichhpuniani J., Bakovic M.;
RT   "Choline transporter-like proteins 1 and 2 are newly identified plasma
RT   membrane and mitochondrial ethanolamine transporters.";
RL   J. Biol. Chem. 296:100604-100604(2021).
CC   -!- FUNCTION: [Isoform 1]: Choline/H+ antiporter, mainly in mitochodria
CC       (PubMed:10677542, PubMed:20665236, PubMed:33789160, PubMed:23651124).
CC       Also acts as a low-affinity ethanolamine/H+ antiporter, regulating the
CC       supply of extracellular ethanolamine (Etn) for the CDP-Etn pathway,
CC       redistribute intracellular Etn and balance the CDP-Cho and CDP-Etn arms
CC       of the Kennedy pathway (PubMed:33789160). {ECO:0000269|PubMed:10677542,
CC       ECO:0000269|PubMed:20665236, ECO:0000269|PubMed:23651124,
CC       ECO:0000269|PubMed:33789160}.
CC   -!- FUNCTION: [Isoform 3]: Does not exhibit choline transporter activity.
CC       {ECO:0000269|PubMed:10677542, ECO:0000269|PubMed:20665236}.
CC   -!- CATALYTIC ACTIVITY: [Isoform 1]:
CC       Reaction=choline(out) + n H(+)(in) = choline(in) + n H(+)(out);
CC         Xref=Rhea:RHEA:75463, ChEBI:CHEBI:15354, ChEBI:CHEBI:15378;
CC         Evidence={ECO:0000269|PubMed:10677542, ECO:0000269|PubMed:20665236,
CC         ECO:0000269|PubMed:23651124, ECO:0000269|PubMed:33789160};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ethanolamine(out) + n H(+)(in) = ethanolamine(in) + n
CC         H(+)(out); Xref=Rhea:RHEA:75467, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57603; Evidence={ECO:0000269|PubMed:33789160};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         Vmax=20.6 nmol/min/mg enzyme {ECO:0000269|PubMed:33789160};
CC       pH dependence:
CC         Optimum pH is 8.5. {ECO:0000269|PubMed:33789160};
CC   -!- SUBUNIT: Interacts with COCH. {ECO:0000269|PubMed:17926100}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305|PubMed:33789160};
CC       Multi-pass membrane protein {ECO:0000255}. Mitochondrion outer membrane
CC       {ECO:0000305|PubMed:33789160}; Multi-pass membrane protein
CC       {ECO:0000255}. Note=Mainly expressed in mitochondria.
CC       {ECO:0000250|UniProtKB:B4F795}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage, Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=CTL2a, CTL2P2A;
CC         IsoId=Q8IWA5-1; Sequence=Displayed;
CC       Name=2; Synonyms=CTL2b, CTL2P2B;
CC         IsoId=Q8IWA5-2; Sequence=VSP_015431;
CC       Name=3; Synonyms=CTL2P1;
CC         IsoId=Q8IWA5-3; Sequence=VSP_041792;
CC   -!- TISSUE SPECIFICITY: Present in supporting cells of the inner ear (at
CC       protein level). {ECO:0000269|PubMed:14973250,
CC       ECO:0000269|PubMed:20665236}.
CC   -!- TISSUE SPECIFICITY: [Isoform 3]: Expressed in inner ear vestibular
CC       tissue. {ECO:0000269|PubMed:20665236}.
CC   -!- MISCELLANEOUS: [Isoform 3]: Produced by alternative promoter usage.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the CTL (choline transporter-like) family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC11662.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ245621; CAB75542.1; -; Genomic_DNA.
DR   EMBL; FN668568; CBJ93592.1; -; mRNA.
DR   EMBL; AK027519; BAG51335.1; -; mRNA.
DR   EMBL; AK294118; BAG57451.1; -; mRNA.
DR   EMBL; AK314582; BAG37158.1; -; mRNA.
DR   EMBL; AC011475; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471106; EAW84126.1; -; Genomic_DNA.
DR   EMBL; BC010617; AAH10617.1; -; mRNA.
DR   EMBL; BC040556; AAH40556.1; -; mRNA.
DR   EMBL; AL832517; CAH56352.1; -; mRNA.
DR   EMBL; AL832978; CAH56342.1; -; mRNA.
DR   EMBL; AK075512; BAC11662.1; ALT_INIT; mRNA.
DR   EMBL; AF070636; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS12245.1; -. [Q8IWA5-1]
DR   CCDS; CCDS54216.1; -. [Q8IWA5-3]
DR   CCDS; CCDS86700.1; -. [Q8IWA5-2]
DR   RefSeq; NP_001138528.1; NM_001145056.1. [Q8IWA5-3]
DR   RefSeq; NP_065161.3; NM_020428.3. [Q8IWA5-1]
DR   RefSeq; XP_005260054.1; XM_005259997.1.
DR   AlphaFoldDB; Q8IWA5; -.
DR   SMR; Q8IWA5; -.
DR   BioGRID; 121410; 15.
DR   IntAct; Q8IWA5; 10.
DR   MINT; Q8IWA5; -.
DR   STRING; 9606.ENSP00000336888; -.
DR   DrugBank; DB00122; Choline.
DR   TCDB; 2.A.92.1.4; the choline transporter-like (ctl) family.
DR   GlyConnect; 1111; 12 N-Linked glycans (2 sites).
DR   GlyCosmos; Q8IWA5; 3 sites, 12 glycans.
DR   GlyGen; Q8IWA5; 4 sites, 12 N-linked glycans (2 sites), 1 O-linked glycan (1 site).
DR   iPTMnet; Q8IWA5; -.
DR   PhosphoSitePlus; Q8IWA5; -.
DR   SwissPalm; Q8IWA5; -.
DR   BioMuta; SLC44A2; -.
DR   DMDM; 311033462; -.
DR   EPD; Q8IWA5; -.
DR   jPOST; Q8IWA5; -.
DR   MassIVE; Q8IWA5; -.
DR   MaxQB; Q8IWA5; -.
DR   PaxDb; Q8IWA5; -.
DR   PeptideAtlas; Q8IWA5; -.
DR   ProteomicsDB; 70829; -. [Q8IWA5-1]
DR   ProteomicsDB; 70830; -. [Q8IWA5-2]
DR   ProteomicsDB; 70831; -. [Q8IWA5-3]
DR   Antibodypedia; 1011; 148 antibodies from 24 providers.
DR   DNASU; 57153; -.
DR   Ensembl; ENST00000335757.10; ENSP00000336888.4; ENSG00000129353.15. [Q8IWA5-1]
DR   Ensembl; ENST00000407327.8; ENSP00000385135.3; ENSG00000129353.15. [Q8IWA5-3]
DR   Ensembl; ENST00000586078.5; ENSP00000466664.1; ENSG00000129353.15. [Q8IWA5-2]
DR   GeneID; 57153; -.
DR   KEGG; hsa:57153; -.
DR   MANE-Select; ENST00000335757.10; ENSP00000336888.4; NM_020428.4; NP_065161.3.
DR   UCSC; uc002mpe.5; human. [Q8IWA5-1]
DR   AGR; HGNC:17292; -.
DR   CTD; 57153; -.
DR   DisGeNET; 57153; -.
DR   GeneCards; SLC44A2; -.
DR   HGNC; HGNC:17292; SLC44A2.
DR   HPA; ENSG00000129353; Low tissue specificity.
DR   MIM; 606106; gene.
DR   neXtProt; NX_Q8IWA5; -.
DR   OpenTargets; ENSG00000129353; -.
DR   PharmGKB; PA142670899; -.
DR   VEuPathDB; HostDB:ENSG00000129353; -.
DR   eggNOG; KOG1362; Eukaryota.
DR   GeneTree; ENSGT00940000158178; -.
DR   HOGENOM; CLU_017181_3_1_1; -.
DR   InParanoid; Q8IWA5; -.
DR   OMA; DWMGRTC; -.
DR   OrthoDB; 551961at2759; -.
DR   PhylomeDB; Q8IWA5; -.
DR   TreeFam; TF313325; -.
DR   PathwayCommons; Q8IWA5; -.
DR   Reactome; R-HSA-1483191; Synthesis of PC.
DR   Reactome; R-HSA-425366; Transport of bile salts and organic acids, metal ions and amine compounds.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   SignaLink; Q8IWA5; -.
DR   SIGNOR; Q8IWA5; -.
DR   BioGRID-ORCS; 57153; 10 hits in 1167 CRISPR screens.
DR   ChiTaRS; SLC44A2; human.
DR   GeneWiki; SLC44A2; -.
DR   GenomeRNAi; 57153; -.
DR   Pharos; Q8IWA5; Tbio.
DR   PRO; PR:Q8IWA5; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q8IWA5; protein.
DR   Bgee; ENSG00000129353; Expressed in tibial nerve and 182 other tissues.
DR   ExpressionAtlas; Q8IWA5; baseline and differential.
DR   Genevisible; Q8IWA5; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005765; C:lysosomal membrane; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:ARUK-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0035579; C:specific granule membrane; TAS:Reactome.
DR   GO; GO:0015220; F:choline transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0034228; F:ethanolamine transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015871; P:choline transport; IDA:UniProtKB.
DR   GO; GO:0034229; P:ethanolamine transport; IDA:UniProtKB.
DR   GO; GO:0006656; P:phosphatidylcholine biosynthetic process; TAS:Reactome.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; HMP:UniProtKB.
DR   GO; GO:0055085; P:transmembrane transport; IDA:ARUK-UCL.
DR   InterPro; IPR007603; Choline_transptr-like.
DR   PANTHER; PTHR12385; CHOLINE TRANSPORTER-LIKE (SLC FAMILY 44); 1.
DR   PANTHER; PTHR12385:SF34; CHOLINE TRANSPORTER-LIKE PROTEIN 2; 1.
DR   Pfam; PF04515; Choline_transpo; 1.
PE   1: Evidence at protein level;
KW   Alternative promoter usage; Alternative splicing; Antiport; Cell membrane;
KW   Glycoprotein; Membrane; Mitochondrion; Mitochondrion outer membrane;
KW   Phosphoprotein; Reference proteome; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN           1..706
FT                   /note="Choline transporter-like protein 2"
FT                   /id="PRO_0000191717"
FT   TOPO_DOM        1..33
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        34..54
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        55..232
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        233..253
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        254..256
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        257..277
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        278..315
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        316..336
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        337..364
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        365..385
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        386..457
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        458..480
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        481..504
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        505..525
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        526..563
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        564..584
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        585..599
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        600..620
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        621..638
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        639..659
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        660..706
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         14
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   CARBOHYD        187
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218,
FT                   ECO:0000269|PubMed:19349973"
FT   CARBOHYD        200
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218,
FT                   ECO:0000269|PubMed:19349973"
FT   CARBOHYD        417
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..12
FT                   /note="MGDERPHYYGKH -> MEDERKNGAY (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039, ECO:0000303|Ref.10"
FT                   /id="VSP_041792"
FT   VAR_SEQ         672..706
FT                   /note="LEDLERNDGSAERPYFMSSTLKKLLNKTNKKAAES -> CEDLERNDGSQER
FT                   PYFMSPELRDILLKGSAEEGKRAEAEE (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:17974005"
FT                   /id="VSP_015431"
FT   VARIANT         154
FT                   /note="Q -> R (in dbSNP:rs2288904)"
FT                   /evidence="ECO:0000269|PubMed:10677542,
FT                   ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:14973250,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17974005,
FT                   ECO:0000269|Ref.6"
FT                   /id="VAR_023404"
FT   CONFLICT        92
FT                   /note="I -> T (in Ref. 4; BAG51335)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        153
FT                   /note="L -> F (in Ref. 3; CBJ93592)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        531
FT                   /note="A -> G (in Ref. 1; CAB75542)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        695
FT                   /note="L -> P (in Ref. 7; AAH40556)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   706 AA;  80124 MW;  9A044A531930326E CRC64;
     MGDERPHYYG KHGTPQKYDP TFKGPIYNRG CTDIICCVFL LLAIVGYVAV GIIAWTHGDP
     RKVIYPTDSR GEFCGQKGTK NENKPYLFYF NIVKCASPLV LLEFQCPTPQ ICVEKCPDRY
     LTYLNARSSR DFEYYKQFCV PGFKNNKGVA EVLQDGDCPA VLIPSKPLAR RCFPAIHAYK
     GVLMVGNETT YEDGHGSRKN ITDLVEGAKK ANGVLEARQL AMRIFEDYTV SWYWIIIGLV
     IAMAMSLLFI ILLRFLAGIM VWVMIIMVIL VLGYGIFHCY MEYSRLRGEA GSDVSLVDLG
     FQTDFRVYLH LRQTWLAFMI ILSILEVIII LLLIFLRKRI LIAIALIKEA SRAVGYVMCS
     LLYPLVTFFL LCLCIAYWAS TAVFLSTSNE AVYKIFDDSP CPFTAKTCNP ETFPSSNESR
     QCPNARCQFA FYGGESGYHR ALLGLQIFNA FMFFWLANFV LALGQVTLAG AFASYYWALR
     KPDDLPAFPL FSAFGRALRY HTGSLAFGAL ILAIVQIIRV ILEYLDQRLK AAENKFAKCL
     MTCLKCCFWC LEKFIKFLNR NAYIMIAIYG TNFCTSARNA FFLLMRNIIR VAVLDKVTDF
     LFLLGKLLIV GSVGILAFFF FTHRIRIVQD TAPPLNYYWV PILTVIVGSY LIAHGFFSVY
     GMCVDTLFLC FLEDLERNDG SAERPYFMSS TLKKLLNKTN KKAAES
//
